JP2017008114A5 - - Google Patents

Download PDF

Info

Publication number
JP2017008114A5
JP2017008114A5 JP2016203842A JP2016203842A JP2017008114A5 JP 2017008114 A5 JP2017008114 A5 JP 2017008114A5 JP 2016203842 A JP2016203842 A JP 2016203842A JP 2016203842 A JP2016203842 A JP 2016203842A JP 2017008114 A5 JP2017008114 A5 JP 2017008114A5
Authority
JP
Japan
Prior art keywords
lipid
aminoglycoside
liposomal
formulation
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016203842A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017008114A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017008114A publication Critical patent/JP2017008114A/ja
Publication of JP2017008114A5 publication Critical patent/JP2017008114A5/ja
Pending legal-status Critical Current

Links

JP2016203842A 2006-04-06 2016-10-17 コアセルベート化誘導リポソーム被包法及びその調合物 Pending JP2017008114A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78968806P 2006-04-06 2006-04-06
US60/789,688 2006-04-06

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2014165736A Division JP6088469B2 (ja) 2006-04-06 2014-08-18 コアセルベート化誘導リポソーム被包法及びその調合物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018000447A Division JP2018048212A (ja) 2006-04-06 2018-01-05 コアセルベート化誘導リポソーム被包法及びその調合物

Publications (2)

Publication Number Publication Date
JP2017008114A JP2017008114A (ja) 2017-01-12
JP2017008114A5 true JP2017008114A5 (enExample) 2017-03-23

Family

ID=38581622

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2009504301A Active JP5600432B2 (ja) 2006-04-06 2007-04-04 コアセルベート化誘導リポソーム被包法及びその調合物
JP2014093375A Pending JP2014139248A (ja) 2006-04-06 2014-04-30 コアセルベート化誘導リポソーム被包法及びその調合物
JP2014165736A Active JP6088469B2 (ja) 2006-04-06 2014-08-18 コアセルベート化誘導リポソーム被包法及びその調合物
JP2016203842A Pending JP2017008114A (ja) 2006-04-06 2016-10-17 コアセルベート化誘導リポソーム被包法及びその調合物
JP2018000447A Pending JP2018048212A (ja) 2006-04-06 2018-01-05 コアセルベート化誘導リポソーム被包法及びその調合物

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2009504301A Active JP5600432B2 (ja) 2006-04-06 2007-04-04 コアセルベート化誘導リポソーム被包法及びその調合物
JP2014093375A Pending JP2014139248A (ja) 2006-04-06 2014-04-30 コアセルベート化誘導リポソーム被包法及びその調合物
JP2014165736A Active JP6088469B2 (ja) 2006-04-06 2014-08-18 コアセルベート化誘導リポソーム被包法及びその調合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018000447A Pending JP2018048212A (ja) 2006-04-06 2018-01-05 コアセルベート化誘導リポソーム被包法及びその調合物

Country Status (5)

Country Link
US (1) US20080089927A1 (enExample)
EP (2) EP2012750B1 (enExample)
JP (5) JP5600432B2 (enExample)
ES (1) ES2668554T3 (enExample)
WO (1) WO2007117550A2 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
ES2439727T3 (es) * 2002-10-29 2014-01-24 Insmed Incorporated Liberación sostenida de antiinfectantes
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
JP4394916B2 (ja) * 2003-09-19 2010-01-06 独立行政法人科学技術振興機構 人工脂質二重膜の形成装置および人工脂質二重膜の形成方法、並びにその利用
AU2006322076C1 (en) 2005-12-08 2013-11-14 Insmed Incorporated Lipid-based compositions of antiinfectives for treating pulmonary infections
US20100196455A1 (en) * 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
ITRM20070681A1 (it) * 2007-12-28 2009-06-29 Carlo Tascini Composizione liposomiale di colistina per uso terapeutico endovenoso orale e cutaneo
BRPI0923001A2 (pt) * 2008-12-17 2018-09-18 Oncothyreon Inc método de produção de lipossomas pequenos
MX369828B (es) 2012-05-21 2019-11-22 Insmed Inc Sistemas para tratar infecciones pulmonares.
ES2743039T3 (es) 2012-11-29 2020-02-18 Insmed Inc Formulaciones de vancomicina estabilizada
US9603799B2 (en) * 2013-03-15 2017-03-28 Htd Biosystems Inc. Liposomal vaccine adjuvants and methods of making and using same
US20160175553A1 (en) 2013-07-17 2016-06-23 Insmed Incorporated Low resistance aerosol exhalation filter
EP3466432B1 (en) 2014-05-15 2020-07-08 Insmed Incorporated Methods for treating pulmonary non-tuberculous mycobacterial infections
WO2019191627A1 (en) 2018-03-30 2019-10-03 Insmed Incorporated Methods for continuous manufacture of liposomal drug products
US20210113467A1 (en) * 2018-05-02 2021-04-22 Robert Worsham Methods for the manufacture of liposomal drug formulations
CN116437929B (zh) * 2020-07-02 2025-11-11 普渡研究基金会 抗微生物化合物的吸入制剂
CN116035946B (zh) * 2022-10-25 2025-07-25 上海美自无双生物科技有限公司 一种通过复合凝聚法制备神经酰胺细胞磷脂组合物的方法及应用
WO2024249293A1 (en) * 2023-05-26 2024-12-05 The Curators Of The University Of Missouri Controlled release of therapeutic proteins for immunomodulation

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4547490A (en) * 1981-12-31 1985-10-15 Neomed, Inc. Synthetic whole blood and a method of making the same
US4606939A (en) * 1983-06-22 1986-08-19 The Ohio State University Research Foundation Small particle formation
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
US4794000A (en) * 1987-01-08 1988-12-27 Synthetic Blood Corporation Coacervate-based oral delivery system for medically useful compositions
US4880635B1 (en) 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
US5736155A (en) 1984-08-08 1998-04-07 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
IL91664A (en) 1988-09-28 1993-05-13 Yissum Res Dev Co Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
IT1245761B (it) * 1991-01-30 1994-10-14 Alfa Wassermann Spa Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.
EP0707472B1 (en) * 1993-07-08 2001-03-14 The Liposome Company, Inc. Method of controlling the size of liposomes
JPH09506866A (ja) * 1993-12-14 1997-07-08 ジョーンズ ホプキンス ユニバーシティー スクール オブ メディシン 医薬として活性のある物質の免疫療法のための放出制御
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
US5800833A (en) 1995-02-27 1998-09-01 University Of British Columbia Method for loading lipid vesicles
US5840702A (en) * 1996-03-22 1998-11-24 Uab Research Foundation Cystic fibrosis treatment
US6503881B2 (en) * 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
US5837282A (en) 1996-10-30 1998-11-17 University Of British Columbia Ionophore-mediated liposome loading
DK1024814T3 (da) * 1997-10-22 2008-01-02 Jens Ponikau Anvendelse af antisvampemidler til topisk behandling af svampe-induceret mucositis
US6916490B1 (en) * 1998-07-23 2005-07-12 UAB Research Center Controlled release of bioactive substances
US6855296B1 (en) * 1998-11-13 2005-02-15 Optime Therapeutics, Inc. Method and apparatus for liposome production
SI20959A (sl) * 1998-12-17 2003-02-28 Pathogenesis Corporation Metoda za zdravljenje hudega kroničnega bronhitisa (bronhiektazije) z aerosoliziranimi antibiotiki
AU773515B2 (en) * 1999-02-08 2004-05-27 Alza Corporation Method for controlling liposome size
AU771706B2 (en) * 1999-07-15 2004-04-01 University Of British Columbia, The Methods and apparatus for preparation of lipid vesicles
US6962151B1 (en) * 1999-11-05 2005-11-08 Pari GmbH Spezialisten für effektive Inhalation Inhalation nebulizer
ATE341310T1 (de) * 2000-02-04 2006-10-15 Lipoxen Technologies Ltd Dehydratisierungs-/rehydratisierungsverfahren zur herstellung von liposome
US7600511B2 (en) * 2001-11-01 2009-10-13 Novartis Pharma Ag Apparatus and methods for delivery of medicament to a respiratory system
MXPA02010884A (es) * 2000-05-05 2003-03-27 Aerogen Ireland Ltd Aparato y metodo para el suministro de medicamentos al sistema respiratorio.
US6948491B2 (en) * 2001-03-20 2005-09-27 Aerogen, Inc. Convertible fluid feed system with comformable reservoir and methods
US7971588B2 (en) * 2000-05-05 2011-07-05 Novartis Ag Methods and systems for operating an aerosol generator
US8336545B2 (en) * 2000-05-05 2012-12-25 Novartis Pharma Ag Methods and systems for operating an aerosol generator
US7100600B2 (en) * 2001-03-20 2006-09-05 Aerogen, Inc. Fluid filled ampoules and methods for their use in aerosolizers
EP1203614A1 (de) * 2000-11-03 2002-05-08 Polymun Scientific Immunbiologische Forschung GmbH Verfahren und Vorrichtung zur Herstellung von Lipidvesikeln
DE10109897A1 (de) * 2001-02-21 2002-11-07 Novosom Ag Fakultativ kationische Liposomen und Verwendung dieser
WO2003053411A1 (en) * 2001-12-19 2003-07-03 Nektar Therapeutics Pulmonary delivery of aminoglycosides
EP1474196B1 (en) * 2002-01-15 2016-08-17 Novartis AG Methods and systems for operating an aerosol generator
WO2003075889A1 (en) * 2002-03-05 2003-09-18 Transave, Inc. An inhalation system for prevention and treatment of intracellular infections
US7901708B2 (en) * 2002-06-28 2011-03-08 Protiva Biotherapeutics, Inc. Liposomal apparatus and manufacturing methods
KR100489701B1 (ko) * 2002-10-09 2005-05-16 주식회사 태평양 고농도의 트리터페노이드를 함유하는 미소화 리포좀 및 그제조방법
ES2439727T3 (es) 2002-10-29 2014-01-24 Insmed Incorporated Liberación sostenida de antiinfectantes
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
US7718189B2 (en) * 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
US7968115B2 (en) * 2004-03-05 2011-06-28 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of cancer
GB2388581A (en) * 2003-08-22 2003-11-19 Danisco Coated aqueous beads
US7556799B2 (en) * 2004-03-30 2009-07-07 Relypsa, Inc. Ion binding polymers and uses thereof
JP4452799B2 (ja) * 2004-07-14 2010-04-21 独立行政法人産業技術総合研究所 コアセルベートを活用したリポソームの製造方法
JP2006077843A (ja) * 2004-09-08 2006-03-23 Aichi Mach Ind Co Ltd 軸部材の支持構造
JP2006263054A (ja) * 2005-03-23 2006-10-05 Konica Minolta Sensing Inc 呼吸器系疾患関連解析データの取得方法、オキシメータシステム及びその動作プログラム、オキシメータ並びに酸素補給システム
JP5639338B2 (ja) * 2005-07-27 2014-12-10 プロチバ バイオセラピューティクス インコーポレイティッド リポソームの製造システムおよび製造方法
KR100705981B1 (ko) * 2005-10-12 2007-04-10 주식회사 리제론 인간 성장호르몬을 포함하는 탈모방지 또는 발모촉진용조성물
AU2006322076C1 (en) * 2005-12-08 2013-11-14 Insmed Incorporated Lipid-based compositions of antiinfectives for treating pulmonary infections
US8268347B1 (en) * 2006-10-24 2012-09-18 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
US8119156B2 (en) * 2006-10-24 2012-02-21 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
US20100196455A1 (en) * 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9333214B2 (en) * 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) * 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
WO2009037970A1 (ja) * 2007-09-21 2009-03-26 Murata Manufacturing Co., Ltd. 落下検知装置、磁気ディスク装置および携帯電子機器
WO2012007130A1 (en) * 2010-07-12 2012-01-19 Xellia Pharmaceuticals Aps Treatment of lung infections by administration of tobramycin by aerolisation
MX369828B (es) * 2012-05-21 2019-11-22 Insmed Inc Sistemas para tratar infecciones pulmonares.

Similar Documents

Publication Publication Date Title
JP2017008114A5 (enExample)
JP2528153B2 (ja) リポソ―ム製剤および抗生物質
ME02518B (me) Smeša lipozoma
HRP20230063T1 (hr) Spoj i pripravci za intracelularnu isporuku terapijskih sredstava
JP2009528340A5 (enExample)
JP2016529284A5 (enExample)
JP2018507227A (ja) 二薬搭載リポソーム医薬製剤
JP6893245B2 (ja) 脂質ナノ粒子用膜材料組成物
JPH08508046A (ja) タキソール製剤
JP2014513135A5 (enExample)
CN103893123A (zh) 一种脂质体-聚合物杂化纳米粒子及其制备方法和应用
Debnath et al. Structural and functional significance of niosome and proniosome in drug delivery system
WO2014022414A1 (en) Cochleates made with soy phosphatidylserine
PL226015B1 (pl) Liposomowy preparat zawierajacy przeciwnowotworowa substancje aktywna, sposob jego wytwarzania i zawierajaca go kompozycja farmaceutyczna
CN101579314A (zh) 有机-无机复合脂质体的抗癌药物缓释制剂及其制备方法
JP2024075590A (ja) リポソーム薬物製剤の製造方法
CN103082031A (zh) 一种鱼油纳米脂质体的制备方法
CN113384530A (zh) 一种多糖核心Nanocells及其制备方法与应用
CN101804028A (zh) 一种中药脂质体的制备方法
JP2008542402A5 (enExample)
TWI249408B (en) New antifungal formulation and manufacturing method thereof
JP6322733B2 (ja) 親水性領域において正の全電荷を示す両親媒性分子種aおよび両親媒性分子種bおよびポリフェノールcを含む分子混合物、該分子混合物の製造方法、ならびにその使用
CN105534905A (zh) 一种含有恩替卡韦的多囊脂质体及其制备方法
TWI459967B (zh) 人造油體及其製造方法
CN109077997B (zh) 培美曲塞二钠脂质复合物及其制备方法